Gainers
- Medalist Diversified REIT, Inc. MDRR shares climbed 147.8% to close at $2.85 on Wednesday. Medalist Diversified REIT announced a dividend for the third quarter on its 8.0% Series A Cumulative Redeemable Preferred Stock in the amount of $0.5000 per share.
- Replimune Group, Inc. REPL shares surged 46.8% to close at $36.25 on Wednesday following recent press release highlighting upcoming November 11, 12 presentations at Society for Immunotherapy of Cancer.
- Interpace Biosciences, Inc. IDXG shares gained 32.9% to close at $3.96. Interpace Biosciences said the Audit Committee investigation found billing and compliance complaints unsubstantiated.
- Allscripts Healthcare Solutions, Inc. MDRX shares climbed 31.2% to close at $10.90 after the company agreed to sell its CarePort Health business to WellSky for $1.35 billion.
- VOXX International Corp VOXX jumped 31% to close at $11.32 after the company swung to a profit in the second quarter.
- Novan Inc NOVN gained 24.1% to close at $0.5710 after the company announced in vitro results showing the effect of NITRICIL against Covid-19.
- Oncorus, Inc. ONCR jumped 23.6% to close at $18.55. Oncorus recently priced its IPO at $15 per share.
- NIO Limited NIO rose 23% to close at $26.60. JP Morgan upgraded NIO from Neutral to Overweight and announced a $40 price target. The company’s annual Nio Day, which is customarily held in December, has been pushed back and will be held Jan. 9, 2021.
- Nano Dimension Ltd. NNDM surged 22.1% to close at $ 3.65. Nano Dimension, earlier during October, priced its 7.35 million ADS registered direct offering at $2.30 per ADS.
- Net Element, Inc. NETE rose 20.8% to close at $ 8.88.
- OncoCyte Corp OCX shares gained 19.9% to close at $1.75 after the company announced new prospective data demonstrating that treatment informed by DetermaRx significantly improves lung cancer survival.
- Humanigen, Inc. HGEN jumped 19% to close at $14.31. HC Wainwright & Co. initiated coverage on Humanigen with a Buy rating and announced a price target of $31.
- Comstock Holding Companies, Inc. CHCI gained 18.5% to close at $2.82.
- Betterware de Mexico, S.A.B. de C.V. BWMX jumped 17.6% to close at $25.81.
- Oblong Inc. OBLG shares climbed 16.7% to close at $3.21. Oblong recently announced new patents for remote work to enhance current and planned multi-share collaboration offerings.
- Electrameccanica Vehicles Corp. SOLO gained 16.6% to close at $3.23. ElectraMeccanica recently named Arizona and Tennessee as two finalist states for SOLO EV U.S. assembly facility and engineering technical center.
- AnaptysBio, Inc. ANAB shares surged 14.7% to close at $20.37 after Guggenheim upgraded the stock from Neutral to Buy and announced a price target of $36 per share. AnaptysBio yesterday reported positive topline data from GALLOP Phase 2 clinical trial of imsidolimab in moderate-to-severe generalized pustular psoriasis.
- Trinity Biotech plc TRIB rose 14.5% to close at $2.61.
- ClearPoint Neuro, Inc. CLPT gained 13.1% to close at $6.30. ClearPoint Neuro, last month, named Danilo D'Alessandro as CFO.
- Diginex Limited EQOS shares rose 12.3% to close at $7.04.
- XPeng Inc. XPEV gained 12.3% to close at $22.05. XPeng recently disclosed a record month and quarter in terms of electric vehicle deliveries.
- Eton Pharmaceuticals, Inc. ETON climbed 12.1% to close at $7.77. Eton Pharma priced its 2.8 million shares at $7 per share.
- LSB Industries, Inc. LXU gained 11.4% to close at $2.34. LSB Industries recently won a 7-year Nitric Acid contract.
- Centennial Resource Development, Inc. CDEV shares gained 10.2% to close at $0.682 as the company reported that JP Morgan Chase Bank has reaffirmed borrowing base of $700 million. The company also reported liquidity increased by 6% versus the prior quarter.
- Concho Resources Inc CXO rose 10.2% to close at $48.66. Bloomberg reported that Concophillips is in talks to acquire Concho.
- China Finance Online Co. Limited JRJC gained 10.1% to close at $9.75.
- Hyliion Holdings Corp. HYLN jumped 10% to close at $29.14 after Axioma disclosed a 10.82% active stake in the company.
- Theravance Biopharma, Inc. TBPH gained 9.6% to close at $18.94. Morgan Stanley upgraded Theravance Biopharma from Equal-Weight to Overweight.
- Bed Bath & Beyond Inc. BBBY gained 8.1% to close at $23.94 after the company announced plans to sell its non-core assets.
- Grubhub Inc. GRUB gained 7.2% to close at $81.29 after Just Eat Takeaway reported positive Q3 trends. Shareholders of Just Eat Takeaway.com NV recently approved a proposed acquisition of GrubHub.
- Viper Energy Partners LP VNOM gained 5.7% to close at $7.95 after the company announced its average Q3 production of barrels of oil per day. ScotiaBank also maintained its Sector Perform rating on the stock and raised its price target from $12 to $13 per share.
- Taiwan Liposome Company, Ltd. TLC shares rose 5.2% to close at $4.85 as the company disclosed that it has enrolled first subject in Phase I clinical trial of inhalable anti-COVID-19 program.
- GameStop Corp. GME shares rose 3.1% to close at $12.25 after Richard Mashaal’s hedge fund firm, Senvest Management LLC, purchased over 3.6 million common stock representing a 5.54% stake in GameStop last week.
Check out these big penny stock gainers and losers
Losers
- Cyclerion Therapeutics, Inc. CYCN shares tumbled 53% to close at $3.35 on Wednesday following a couple of clinical trial updates from the company. Cyclerion said its mid-stage investigational asset olinciguat did not show adequate activity to support further internal clinical development of it as a potential treatment for sickle cell disease. Separately, the company announced positive results from a Phase 1 translational pharmacology study of IW-6463, a soluble guanylate cyclase stimulator being developed for CNS disorders.
- Codiak BioSciences, Inc. CDAK dipped 19.2% to close at $12.12 after pricing its IPO at $15 per share.
- Navistar International Corporation NAV shares declined 19% to close at $36.00. TRATON Group is giving Navistar International until noon Friday to accept its $43-a-share bid for the 83% of the company it does not already own.
- Liquidia Technologies, Inc. LQDA fell 18.1% to close at $3.34. Liquidia Technologies reported that U.S. Patent Trial and Appeal Board has ruled against United Therapeutics on Tyvaso patents.
- Enzo Biochem, Inc. ENZ fell 17.2% to close at $2.16. Enzo Biochem reported fourth-quarter revenues of $19.5 million, down 6.6% year-over-year, while on a GAAP basis, the net loss narrowed from 11 cents per share to 7 cents per share.
- AMC Entertainment Holdings, Inc. AMC dropped 16.4% to close at $2.96. The world’s biggest chain of theaters - AMC Entertainment is mulling options for respite from debt, that includes potential bankruptcy, Bloomberg reported.
- Sorrento Therapeutics, Inc. SRNE fell 15.5% to close at $10.10. Sorrento Therapeutics yesterday said it has entered into an exclusive license agreement with Personalized Stem Cells, Inc. to acquire global rights to its adipose-derived mesenchymal stem cells for patients suffering from acute respiratory distress syndrome-associated with COVID-19.
- Hexindai Inc. HX dipped 14.4% to close at $1.78.
- Adaptimmune Therapeutics plc ADAP dropped 13.6% to close at $7.95.
- Nxt-ID, Inc. NXTD shares fell 13.4% to close at $0.3450 after climbing around 20% on Tuesday. Nxt-ID announced plans to adjourn the Annual Meeting of Stockholders.
- Mercurity Fintech Holding Inc. MFH fell 12.5% to close at $2.59 after climbing over 18% on Tuesday.
- Medigus Ltd. MDGS tumbled 11.8% to close at $2.55. Medigus announced plans to take a 33% interest in internet company Gix.
- Dynavax Technologies Corporation DVAX dropped 11.6% to close at $4.59. Dynavax Technologies shares rose 12% on Tuesday after the company announced Medigen's COVID-19 vaccine combined with its CpG 1018 Adjuvant received Taiwan Government Subsidy.
- Prelude Therapeutics Incorporated PRLD fell 10.1% to close at $35.01. Baker Bros. Advisors recently disclosed a 31.1% stake in Prelude Therapeutics.
- Altimmune, Inc. ALT dipped 10% to close at $12.80. Altimmune yesterday published positive pre-clinical data on its new COVID-19 vaccine candidate.
- Lazydays Holdings, Inc. LAZY dropped 9.1% to close at $15.28 after the company announced a common stock offering of 4 million shares.
- iBio, Inc. IBIO fell 8.5% to close at $2.05 after reporting a decline in FY20 sales.
- Wah Fu Education Group Limited WAFU fell 7.2% to close at $4.38 after declining over 31% on Tuesday.
- RAVE Restaurant Group, Inc. RAVE fell 7.2% to close at $0.7605. RAVE Restaurant Group, recently, announced hiring of two new executives to fuel franchise development.
- Blonder Tongue Laboratories, Inc. BDR fell 6.7% to close at $1.40. Blonder Tongue shares jumped 34% on Tuesday after the company reported U.S. patent grant for its networking modules for display systems.
- JAKKS Pacific, Inc. JAKK dropped 6.2% to close at $4.12. JAKKS Pacific, last month, entered into a deal to create toy line based on Haribo products.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Posted In: NewsPenny StocksPre-Market OutlookMarketsMoversTrading IdeasConstruction & Farm Machinery & Heavy TrucksDiversified ChemicalsHealth CareIndustrialsInformation TechnologyIT Consulting & Other ServicesMaterialsMovers From YesterdayPharmaceuticalsTop Gainers
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in